ADVERTISEMENT

Satnam Singh Bhamara, India’s 1st Player in NBA, Banned for Doping

He finished with four points, three rebounds, and an assist in 10 minutes of action on his debut.

Published
Other Sports
1 min read
Satnam Singh Bhamara, India’s 1st Player in NBA, Banned for Doping
i

Basketball player, Satnam Singh Bhamara, who had created history after becoming the first Indian to be picked in an NBA draft in 2015, has been banned for two years for doping.

The Anti Doping Disciplinary Panel of National Anti-Doping Agency (NADA) has imposed the ban on Satnam after he tested positive for Higenamine Beta-2-Agonist.

ADVERTISEMENT

"Satnam Singh Bhamara, basketball player, tested positive for Higenamine Beta-2-Agonist. Anti Doping Discpilinary Panel has imposed two years ineligbility on him," NADA said in a tweet on Thursday.

Higenamine was added to the World Anti-Doping Agency (WADA) Prohibited List in 2017 and is classified as a beta-2 agonist, which means it is prohibited at all times, both in and out-of-competition.

Satnam, who plays the centre position, was named to the opening night roster of the Texas Legends - the D League affiliate of the Dallas Mavericks, the team that drafted him 52nd overall in the 2015 draft.

He made his debut on opening night of the 2015-16 G League season, in the team's season opener against the Austin Spurs. He finished with four points, three rebounds, and an assist in 10 minutes of action.

He played another season -- the 2016-17 campaign -- in the G League as a member of the Texas Legends before returning to India.

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

Read and Breaking News at the Quint, browse for more from sports and other-sports

Topics:  NBA 

ADVERTISEMENT
Speaking truth to power requires allies like you.
Become a Quint Insider
25
100
200

or more

PREMIUM

3 months
12 months
12 months
Check Insider Benefits
Read More
ADVERTISEMENT
Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!
ADVERTISEMENT
More News
×
×